Dr. Le DERM Psoriasis Cream, developed by professional dermatologists, treats the symptoms of psoriasis while hydrating and rebuilding the skin's protective barrier. An anti-psoriasis medication removes dander and dead cells and helps restore moisture to the skin, preventing symptoms of psoriasis from recurring. The use of the drug helps to quickly stop the aggravated symptoms and to cure psoriasis in a short time.
Pre-cleanse the skin with a neutral lotion. Apply Dr. DERM to affected areas one to four times daily or as directed by a healthcare practitioner. You can also view the patient information included with the product.
Instructions for applying the preparation:
Inflamed skin is sensitive to UV rays. Avoid direct sunlight on the sores during treatment. Use sunscreen, wear protective clothing, and limit sun exposure while using Dr. DERM and for one week after completing treatment procedures. The recommended treatment is 28 days. Doctors advise to repeat the treatment after 2-3 months for the purpose of prevention.
Term | Effect |
---|---|
Week 1 | The cream removes inflammation, itching, flaking, plaques. |
Week 2 | The process of regeneration of damaged tissue is initiated due to the normalization of the cell division cycle. |
Week 3 | Body pH is normalized, skin tone is increased. The skin becomes firm and elastic. |
Week 4 | If you are on a diet, the disease will not get worse. |
Dr. DERM is indicated for the treatment of mild to moderate psoriasis. The drug reduces inflammation, reduces itching, and slows cell production. Types of psoriasis for which the use of the cream is recommended:
Dr. DERM should be applied directly to the affected area during treatment or when symptoms occur.
Psoriasis medication Dr. DERM is based on natural hypoallergenic components and does not cause side reactions. The use of the drug is not recommended in the following cases:
Care should be taken when using the cream in case of a pronounced allergic reaction to the components of the drug. The drug has passed all stages of clinical trials under laboratory conditions in Hungary.